exoRBD (Codiak BioSciences)

N/A

Report date: 2022/10/17 09:54:51

Base Information

Drug NameexoRBD (Codiak BioSciences)
Drug Alias NameexoVACC based therapies (Codiak BioSciences)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodiak Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesCodiak Biosciences
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A